Pairing GLP-1 medicines with SGLT2 inhibitors is emerging as a strategy for stronger heart and kidney protection
Ozempic is approved by the Food and Drug Administration (FDA) for the following uses: to improve blood sugar management in adults who have type 2 diabetes, when used along with diet and exercise to reduce the risk of major cardiovascular events (those related to the heart and blood vessels, such as heart attack, stroke, and death) in adults who have type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes The FDA has not approved Ozempic for weight loss or long-term weight management
Effects of baseline serum uric acid and apolipoprotein E4 on longitudinal cognition and cerebral metabolism
Companion foods should offer small portion sizes, high nutrient density, and great taste to support GLP-1 patients effectively
Q Where does Quvara Medical fit into this landscape
The Kjeldahl method was used to determine the crude protein content in diets (FOSS, KjeltecTM 8200)